What’s Next For MRNA Technology

With demand for COVID-19 vaccines slowing, what’s next for mRNA? And what can pharmaceutical companies do to make the most of the research and production capacity that’s available to them? Latika Mahajan, Assistant Manager, Life Sciences at The Smart Cube, delves into this exciting opportunity.